Fenghua W. Wang
Guangzhou, 510030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Chinese guidelines for HER2-targeted therapy in gastric and gastroesophageal junction adenocarcinoma (2025 Edition).
Journal: Journal of hematology & oncology
Published: February 02, 2026
Chinese consensus on first-line precision therapy for advanced gastric cancer.
Journal: Innovation (Cambridge (Mass.))
Published: September 16, 2025
deltaHED predicts survival and immune evasion in PD-1 blockade therapy: A multi-cohort study across three cancer types.
Journal: Clinical and translational medicine
Published: September 16, 2025
Efficacy and safety of TAS-102 plus Surufatinib in third and later line metastatic pancreatic cancer: a prospective, single center and biomarker exploratory, phase II study.
Journal: Molecular cancer
Published: May 29, 2025
Efficacy and Safety of Different Sequences for mFOLFIRINOX (or SOXIRI) and Gemcitabine Plus Albumin-Bound Paclitaxel in Unresectable Pancreatic Cancer.
Journal: ImmunoTargets and therapy
Published: April 24, 2025
GPC3: a novel mutated gene in pleuropulmonary blastoma.
Journal: Discover oncology
Published: January 16, 2025
Genomic and clinical characterization of pediatric lymphoepithelioma-like carcinoma.
Journal: Journal of translational medicine
Published: June 20, 2024
Safety, Pharmacokinetics, and Pharmacodynamics Evaluation of Ivonescimab, a Novel Bispecific Antibody Targeting PD-1 and VEGF, in Chinese Patients With Advanced Solid Tumors.
Journal: Cancer medicine
Published: May 06, 2024
Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers exploration.
Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers exploration.
Journal: Cancer immunology, immunotherapy : CII
Published: April 07, 2024
Anatomical classification of advanced biliary tract cancer predicts programmed cell death protein 1 blockade efficacy.
Journal: Frontiers in pharmacology
Published: January 29, 2024
A near-infrared fluorescence-enhancing plasmonic biosensing microarray identifies soluble PD-L1 and ICAM-1 as predictive checkpoint biomarkers for cancer immunotherapy.
Journal: Biosensors & bioelectronics
Published: January 18, 2023
Efficacy and safety of SOXIRI versus mFOLFIRINOX in advanced pancreatic cancer.
Journal: Therapeutic advances in medical oncology
Published: December 16, 2022
Last Updated: 09/26/2026